ACST - Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earning Call Transcript
Acasti Pharma Inc. (ACST) Q3 2021 Results Conference Call November 10, 2021 4:30 PM ET Company Participants Jan D’Alvise – President and Chief Executive Officer Pierre Lemieux – Chief Operating Officer, Canada, Chief Scientific Officer, and Co-Founder George Kottayil – Chief Operating Officer, U.S. Brian Ford – Chief Financial Officer Prashant Kohli – VP of Commercial Operations David Waldman – Investor Relations Conference Call Participants Nicole Kaufman – Blackridge Capital Jim Caldwell – Analyst Sean Canavan – Analyst Sahil Khathmi – Analyst Presentation Operator Good day, ladies and gentlemen, and welcome to the Acasti Pharma Second Quarter 2022, earnings call. At this time all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, David Waldmann of Investor Relations. Sir, the floor is yours. David Waldman
For further details see:
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earning Call Transcript